MoonLake Immunotherapeutics capital & dividend

Leverage, liquidity, debt coverage and shareholder-distribution metrics.

Leverage

Debt / equity: 0.40x
Net debt / equity: -0.78x
Debt / assets: 0.25x
Debt / EBITDA: -0.41x
Net debt / EBITDA: 0.80x

Liquidity & coverage

Current ratio: 8.60x
Quick ratio: 8.60x
Cash ratio: 7.76x
Interest coverage: -28.15x
EBITDA / interest: -25.88x
Working capital: $350.5M

Cash & dividend

FCF / debt: -2.22x
Cash flow / debt: -2.22x
Dividend per share: —
Dividend yield: —
Dividend growth 1y: —

Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.